Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:24 AM
Ignite Modification Date:
2025-12-25 @ 2:24 AM
NCT ID:
NCT03388034
Eligibility Criteria:
Inclusion Criteria (Cohort 1):
* Infants under 6 months old
* Presenting clinical signs of a whooping cough syndrome
* Written consent obtained from a parent/guardian of the child
Inclusion Criteria (Cohort 2):
* People in regular and prolonged contact (\>3h per day) with the index case for at least 15 days before the signs of whooping cough occurred in the infected child, living (or not) in the same household.
* For the adults, written consent obtained.
* For minors under 7 yo: written consent obtained from a parent/guardian.
* For minors over 7 yo: written consent obtained from parent/guardian and oral assent obtained from the child.
Inclusion Criteria (Cohort 3):
* Child aged between 3 and 15 yo
* Up to date first pertussis vaccination (vaccination booklet or official register)
* Last pertussis vaccination done more than one year before inclusion
* For minors under 7 yo: written consent obtained from parent/guardian.
* For minors over 7 yo: written consent obtained from parent/guardian and oral assent obtained from the child.
Exclusion Criteria (Cohort 3):
* Pertussis vaccination done more than one year before inclusion
Healthy Volunteers:
True
Sex:
ALL
Study:
NCT03388034
Study Brief:
Protocol Section:
NCT03388034